Gene and Cell Therapy (GCT) Market - Analysis By Vector, Application, By Region, By Country (2021 Edition): Market Insights, Pipeline, Forecast with Impact of COVID-19 (2021-2026)

Report
200 Pages
September 2021
Region: Global
Azoth Analytics
ID: 5448569

The Global Gene and Cell Therapy (GCT) Market is estimated at USD 2504.2 Million in the year 2020. Growth in the historic period in the cell and gene therapy market resulted from increase in investments in cell and gene therapies, growth in research and development, advances in cancer drug discovery, rise in public-private partnerships, strong economic growth in emerging markets, increased healthcare expenditure, and rising in pharmaceutical R&D expenditure.

Companies in the gene and cell therapy for oncology market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive market, organizations are developing innovative products as well as sharing skills and expertise with other such enterprises. While oncology drug companies have long collaborated with each other as well as with academic and research institutions in this market by way of partnerships, in or out licensing deals, this trend has been increasing over the recent years.

Further, the market was restrained by inadequate reimbursements, challenges due to regulatory changes, low healthcare access, and limited number of treatment centers. Going forward increasing prevalence of cancer and chronic diseases, rising geriatric population, rising geriatric population, rising focus on cell and gene therapy, and rise in healthcare expenditure will drive the growth in the gene and cell therapy market. Factors that could hinder the growth of the market in the future include high costs of therapy, stringent regulations, reimbursement challenges, and coronavirus pandemic.

Scope of the Report

The report presents the analysis of Gene and Cell Therapy market for the historical period 2016-2020 and forecast period of 2021-2026.
The report analyses the Gene and Cell Therapy Market by value (USD Million).
The report analyses the Gene and Cell Therapy Market by Vector (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
The report analyses the Gene and Cell Therapy Market Application (Oncology, Neurological disorders, cardiovascular disorders, Others).
The Global Gene and Cell Therapy Market has been analysed By Region (North America, Europe, Asia Pacific, LAMEA) By Country (United States, Canada, Germany, U.K, France, Italy, China, Japan, India and South Korea).
The key insights of the report have been presented through the frameworks of the attractiveness of the market has been presented by region, by Vector, By Application.
Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include F. Hoffman-La Roche Ltd., Novartis, Sanofi, Alnylam Pharmaceuticals Inc., Pfizer, BlueBird Inc., Sarepta Therapeutics, Voyager Therapeutics, Orchard Therapeutics Plc, AnGes Inc.

Key Target Audience:

Biotechnology Companies
Healthcare Companies
Government and Policy Makers
Regulatory Authorities

1. Report Scope and Methodology

1.Report scope & Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary

2. Strategic Recommendations3. Gene and Cell Therapy Market: Product Outlook

4. Global Gene and Cell Therapy Market: Sizing and Forecast

4.1 Global Gene and Cell Therapy Market Size, By Value, Year 2016-2026

5. Global Gene and Cell Therapy Market Segmentation - By Vector, By Application

5.1 Competitive Scenario of Global Gene and Cell Therapy Market: By Vector
5.1.1 Lentivirus - Market Size and Forecast (2016-2026)
5.1.2 AAV - Market Size and Forecast (2016-2026)
5.1.3 Retrovirus & Gammaretrovirus - Market Size and Forecast (2016-2026)
5.1.4 Others - Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Gene and Cell Therapy Market: By Application
5.2.1 Oncology - Market Size and Forecast (2016-2026)
5.2.2 Neurological Disorders - Market Size and Forecast (2016-2026)
5.2.3 cardiovascular disorders - Market Size and Forecast (2016-2026)
5.2.4 Others - Market Size and Forecast (2016-2026)

6. Global Gene and Cell Therapy Market: Regional Analysis

6.1 Competitive Scenario of Global Gene and Cell Therapy Market: By Region

7. North America Gene and Cell Therapy Market: An Analysis (2016-2026)

7.1 North America Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
7.2 North America Gene and Cell Therapy Market - Prominent Companies
7.3 Market Segmentation By Vector (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
7.4 Market Segmentation By Application (Oncology, Neurological Disorders, cardiovascular disorders and Others)
7.5 North America Gene and Cell Therapy Market: Country Analysis
7.6 Market Opportunity Chart of North America Gene and Cell Therapy Market - By Country, By Value, 2026
7.7 Competitive Scenario of North America Gene and Cell Therapy Market: By Country
7.8 United States Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
7.9 United States Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
7.10 Canada Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
7.11 Canada Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)

8.Europe Gene and Cell Therapy Market: Segmentation: An Analysis (2016-2026)

8.1 Europe Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
8.2 Europe Gene and Cell Therapy Market - Prominent Companies
8.3 Market Segmentation By Vector (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
8.4 Market Segmentation By Application (Oncology, Neurological Disorders, cardiovascular disorders and Others)
8.5 Europe Gene and Cell Therapy Market: Country Analysis
8.6 Market Opportunity Chart of Europe Gene and Cell Therapy Market - By Country, By Value, 2026
8.7 Competitive Scenario of Europe Gene and Cell Therapy Market: By Country
8.8 Germany Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
8.9 Germany Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
8.10 United Kingdom Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
8.11 United Kingdom Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
8.12 France Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
8.13 France Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
8.14 Italy Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
8.15 Italy Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)

9.Asia Pacific Gene and Cell Therapy Market:: An Analysis (2016-2026)

9.1 Asia Pacific Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Gene and Cell Therapy Market - Prominent Companies
9.3 Market Segmentation By Vector (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
9.4 Market Segmentation By Application (Oncology, Neurological Disorders, cardiovascular disorders and Others)
9.5 Asia Pacific Gene and Cell Therapy Market: Country Analysis
9.6 Market Opportunity Chart of Asia Pacific Gene and Cell Therapy Market - By Country, By Value, 2026
9.7 Competitive Scenario of Asia Pacific Gene and Cell Therapy Market: By Country
9.8 China Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
9.9 China Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
9.10 Japan Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
9.11 Japan Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
9.12 India Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
9.13 India Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
9.14 South Korea Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
9.15 South Korea Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value

10.Global Gene and Cell Therapy Market Dynamics

10.1 Drivers
10.2 Restraints
10.3 Trends

11.Market Attractiveness

11.2 Market Attractiveness Chart of Global Gene and Cell Therapy Market - By Vector, 2026
11.3 Market Attractiveness Chart of Global Gene and Cell Therapy Market - Application, 2026
11.4 Market Attractiveness Chart of Global Gene and Cell Therapy Market - By Region, 2026

12.Competitive Landscape

12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Product Pipeline of Leading Gene Therapy Companies
12.3 Market Share Analysis

13.Company Analysis

13.1 F. Hoffman-La Roche Ltd.
13.2 Novartis
13.3 Sanofi
13.4 Alnylam Pharmaceuticals Inc.
13.5 Pfizer
13.6 BlueBird Inc.
13.7 Sarepta Therapeutics
13.8 Voyager Therapeutics
13.9 Orchard Therapeutics Plc
13.10 AnGes Inc.

List of Figures

Global Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Global Current Healthcare Expenditure Per Capita, 2015-018 (In Numbers)
Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Global Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Global Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Global Prevalence of Total Cancer, 2015-2019 (In Millions)
Global Gene and Cell Therapy Market- By Vector Market Share, 2020 & 2026
Global Gene and Cell Therapy Market- By Lentivirus, By Value (USD Million), 2016-2026
Global Gene and Cell Therapy Market- By AAV, By Value (USD Million), 2016-2026
Global Gene and Cell Therapy Market- By Retrovirus & Gammaretrovirus, By Value (USD Million), 2016-2026
Global Gene and Cell Therapy Market- By Others, By Value (USD Million), 2016-2026
Global Gene and Cell Therapy Market- By Application Market Share, 2020 & 2026
Global Gene and Cell Therapy Market- By Oncology, By Value (USD Million), 2016-2026
Global Gene and Cell Therapy Market- By Neurological disorders , By Value (USD Million), 2016-2026
Global Gene and Cell Therapy Market- By cardiovascular disorders, By Value (USD Million), 2016-2026
Global Gene and Cell Therapy Market- By Others, By Value (USD Million), 2016-2026
Global Gene and Cell Therapy Market- By Region Market Share, 2020 & 2026
North America Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
North America Prevalence of Neurological Disorders, 2015-2019 (In Millions)
North America Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
North America Prevalence of Total Cancer, 2015-2019 (In Millions)
North America Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
North America Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Market Opportunity Chart of North America Gene and Cell Therapy Market- By Country, By Value (Year-2026)
North America Gene and Cell Therapy Market- By Country Market Share, 2020 & 2026
United States Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
United State Prevalence of Neurological Disorders, 2015-2019 (In Millions)
United State Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
United State Prevalence of Total Cancer, 2015-2019 (In Millions)
United State Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
United State Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Canada Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Canada Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Canada Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Canada Prevalence of Total Cancer, 2015-2019 (In Millions)
Canada Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Canada Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Europe Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Europe Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Europe Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Europe Prevalence of Total Cancer, 2015-2019 (In Millions)
Europe Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Europe Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Market Opportunity Chart of Europe Gene and Cell Therapy Market- By Country, By Value (Year-2026)
Europe Gene and Cell Therapy Market- By Country Market Share, 2020 & 2026
Germany Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Germany Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Germany Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Germany Prevalence of Total Cancer, 2015-2019 (In Millions)
Germany Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Germany Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
United Kingdom Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
United Kingdom Prevalence of Neurological Disorders, 2015-2019 (In Millions)
United Kingdom Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
United Kingdom Prevalence of Total Cancer, 2015-2019 (In Millions)
United Kingdom Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
United Kingdom Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
France Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
France Prevalence of Neurological Disorders, 2015-2019 (In Millions)
France Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
France Prevalence of Total Cancer, 2015-2019 (In Millions)
France Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
France Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Italy Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Billion)
Italy Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Italy Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Italy Prevalence of Total Cancer, 2015-2019 (In Millions)
Italy Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Italy Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Asia Pacific Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Asia Pacific Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Asia Pacific Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Asia Pacific Prevalence of Total Cancer, 2015-2019 (In Millions)
Asia Pacific Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Asia Pacific Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Market Opportunity Chart of APAC Gene and Cell Therapy Market- By Country, By Value (Year-2026)
APAC Gene and Cell Therapy Market- By Country Market Share, 2020 & 2026
China Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
China Prevalence of Neurological Disorders, 2015-2019 (In Millions)
China Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
China Prevalence of Total Cancer, 2015-2019 (In Millions)
China Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
China Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Japan Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Japan Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Japan Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Japan Prevalence of Total Cancer, 2015-2019 (In Millions)
Japan Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Japan Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
India Pharmacy Retail Market Size, By Value, 2016-2026 (USD Billion)
India Prevalence of Neurological Disorders, 2015-2019 (In Millions)
India Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
India Prevalence of Total Cancer, 2015-2019 (In Millions)
India Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
India Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
South Korea Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
South Korea Prevalence of Neurological Disorders, 2015-2019 (In Millions)
South Korea Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
South Korea Prevalence of Total Cancer, 2015-2019 (In Millions)
South Korea Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
South Korea Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Market Attractiveness Chart of Global Gene and Cell Therapy Market- By Vector (Year-2026)
Market Attractiveness Chart of Global Gene and Cell Therapy Market- By Application (Year-2026)
Market Attractiveness Chart of Global Gene and Cell Therapy Market- By Region (Year-2026)
Global Gene and Cell Therapy company market share (%), 2020
F. Hoffman-La Roche Ltd. Sales Revenues, 2016-2020 (USD Million)
F. Hoffman-La Roche Ltd. Net Income, 2016-2020 (USD Million)
F. Hoffman-La Roche Ltd. sales Revenues, By Business Segment (%), FY2020
F. Hoffman-La Roche Ltd. sales Revenue, By Geographical Segment (%), FY2020
Novartis Annual Sales Revenue (USD Million), 2016-2020
Novartis Annual Net Income/Loss (USD Million), 2016-2020
Novartis Sales Revenue Split, By Business Segment (USD Million), FY2020
Novartis Sales Revenue Split, By Geography Segment (%), FY2020
Sanofi Sales Revenues, 2016-2020 (USD Million)
Sanofi Gross Profit, 2016-2020 (USD Million)
Sanofi Sales Revenue Split, By Business Segment (%), FY2020
Sanofi Sales Revenue Split, By Geography Segment (%), FY2020
Alnylam Pharmaceuticals Inc. Sales Revenues, 2016-2020 (USD Million)
Alnylam Pharmaceuticals Inc. sales Revenues, By Business Segment (%), FY2020
Alnylam Pharmaceuticals Inc. sales Revenue, By Geographical Segment (%), FY2020
Pfizer Annual Sales Revenue (USD Million), 2016-2020
Pfizer Annual Net Income/Loss (USD Million), 2016-2020
Pfizer sales Revenue, By Geographical Segment (%), FY2020
BlueBird Bio Inc. Sales Revenues, 2015-2019 (USD Million)
Sarepta Therapeutics Sales Revenues, 2015-2019 (USD Million)
Voyager Therapeutics Sales Revenues, 2015-2019 (USD Million)
Orchard Therapeutics PLC Sales Revenues, 2018-2020 (USD Million)
AnGes Inc. Sales Revenues, 2015-2019 (USD Million)

Table Information

Report Attribute	Details
No. of Pages	200
Published	September 2021
Forecast Period	2021 - 2026
Estimated Market Value in 2021	4.2 Billion
Forecasted Market Value by 2026	66.82 Billion
Compound Annual Growth Rate	73.9%
Regions Covered	Global

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2290EUR$2,400USD£1,918GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€2862EUR$3,000USD£2,398GBP

Scope of the Report

Key Target Audience:

Table of Contents

Table Information

Related Topics

Related Reports

Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029

Cell & Gene Therapy Manufacturing Services Market by Type, Indication, Application, End-User - Global Forecast 2025-2030

Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions

Gene Delivery Technologies Market Size, Share & Trends Analysis Report By Mode (AAV, Lentivirus, Retrovirus), By Application (Gene Therapy, Cell Therapy), By Method (Ex-vivo, In-vivo), By Region, And Segment Forecasts, 2024 - 2030

Cell Therapy Collaboration and Licensing Deals 2016-2024